Search

everythinglearnresearchcommunity

for

Search:↓

Carriers of a specific gene mutation have subtle skin changes without visible symptoms.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Cancer prevention has advanced significantly, with some strategies proving successful.

A gene mutation in mice causes severe skin disorder similar to a human condition.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Enhancing Tregs can protect against alopecia areata.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

The assay effectively identifies compounds that affect immune cell activation.

Peficitinib can turn human fibroblasts into cells that help grow hair.

miR-129-5p affects hair growth by targeting the HOXC13 gene.

Tislelizumab can cause cutaneous lupus erythematosus.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Hair follicles help skin immune recovery after UVB exposure.

Juniperus communis extract enhances the effectiveness of oral cancer treatment when combined with chemotherapy.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Connexin 30 is usually absent in normal skin but can appear in certain skin conditions.

Two gene variations, rs6493497 and rs7176005, may be linked to female hair loss in Chinese people.

The ZIP13 variant is linked to abnormal hair quality.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.